Skip to main content
. 2022 Dec 1;23:438–470. doi: 10.1016/j.bioactmat.2022.11.014

Fig. 13.

Fig. 13

The action modes and representative structures of therapeutic antibodies. Monospecific, bispecific and triple-specific antibodies that target antigens expressed on cancer and/or NK or T cells enable increased engagement of cytotoxic T/NK cells with cancer cells, thereby promoting cancer cell lysis (top). Engineering strategies on the chain structures of therapeutic antibodies allow a wide range of biological functions (bottom). Created with permission by BioRender.